ASCO Guidelines
A podcast by American Society of Clinical Oncology (ASCO)
180 Episoade
-
PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update
Publicat: 03.10.2022 -
Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Update
Publicat: 26.09.2022 -
Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update
Publicat: 21.09.2022 -
Integrative Medicine for Pain Management in Oncology: SIO-ASCO Guideline
Publicat: 19.09.2022 -
Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update
Publicat: 04.08.2022 -
Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO Living Guideline (Part 1)
Publicat: 11.07.2022 -
Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO Living Guideline (Part 2)
Publicat: 11.07.2022 -
Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline Update
Publicat: 27.06.2022 -
Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline
Publicat: 21.06.2022 -
Systemic Therapy for Melanoma Rapid Recommendation Update
Publicat: 03.06.2022 -
Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline Update
Publicat: 31.05.2022 -
Systemic Therapy for Advanced HER2-Positive Breast Cancer Guideline Update
Publicat: 31.05.2022 -
Exercise, Diet, and Weight Management During Cancer Treatment Guideline
Publicat: 16.05.2022 -
Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline
Publicat: 13.05.2022 -
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update
Publicat: 19.04.2022 -
Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update
Publicat: 13.04.2022 -
Management and Care of Patients with Invasive Cervical Cancer: Resource-Stratified Guideline Rapid Recommendation Update
Publicat: 07.03.2022 -
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update
Publicat: 24.02.2022 -
Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer Provisional Clinical Opinion
Publicat: 17.02.2022 -
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected NSCLC Guideline Rapid Recommendation Update
Publicat: 14.02.2022
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
